CN113754648B - Preparation method of xaflufen and intermediate thereof - Google Patents
Preparation method of xaflufen and intermediate thereof Download PDFInfo
- Publication number
- CN113754648B CN113754648B CN202010489058.2A CN202010489058A CN113754648B CN 113754648 B CN113754648 B CN 113754648B CN 202010489058 A CN202010489058 A CN 202010489058A CN 113754648 B CN113754648 B CN 113754648B
- Authority
- CN
- China
- Prior art keywords
- reaction
- acid
- secondary amine
- trifluoromethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention discloses a preparation method of pyraflufen-ethyl and an intermediate thereof, which comprises the steps of carrying out mannich reaction on 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-ol, paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole in an acid environment to obtain an intermediate A, continuously alkylating the intermediate A with monochlorodifluoromethane to obtain an intermediate B, and oxidizing the intermediate B by hydrogen peroxide to obtain the pyraflufen-ethyl. The method has the advantages of high reaction speed, high product purity, high yield, mild reaction conditions, extensive synthesis process, reduced reaction equipment cost, easy separation of the produced product and simplified production process.
Description
Technical Field
The invention relates to a preparation method of a topramezone intermediate, in particular to a method for synthesizing a topramezone intermediate A by adopting 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, cyclo-secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole and a method for synthesizing topramezone by adopting the novel process route, belonging to the technical field of topramezone synthesis.
Background
Pyriflupyrazoxazone (Pyroxasulfone) is an isoxazole herbicide, developed by Nippon combinatorial chemical Co., ltd, and has a chemical name of 3- [5- (difluoromethoxy) -1-methyl-3- (trifluoromethyl) pyrazol-4-ylmethylsulfonyl ] -4, 5-dihydro-5, 5-dimethyl-1, 2-isoxazole with a molecular formula of C 12 H 14 F 5 N 3 O 4 S, molecular weight 391.32, CAS registry number 447399-55-5. The sulfonepyrazoxazole can be used as a pre-emergence soil treatment agent in most crop fields, is absorbed by young roots and young buds of weeds after being applied, inhibits the early growth of seedlings, destroys meristems and coleoptiles, and is a serious potential inhibitor in the biosynthesis of VLCFA (very long chain fatty acid) (C20-C30) in plants. The structure is as follows:
at present, the synthesis process of the xaflufen is rarely reported, and the following process route is disclosed in patent CN 102666502:
under the alkaline condition, 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, formaldehyde water solution and 5, 5-dimethyl-4, 5-dihydro isoxazole sulfamidine hydrochloride are subjected to condensation reaction in water to obtain an intermediate A, the intermediate A is alkylated with monochlorodifluoromethane to obtain an intermediate B, and the intermediate B is oxidized by hydrogen peroxide to obtain the pyraflufen-ethyl.
In the process route, the yield of the sulfonepyraflufen-ethyl is too low, and the formaldehyde aqueous solvent is easy to cause distortion and has great harm to the environment and human beings.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a preparation method of the intermediate A of the sulfuryl pyraoxystrobin, and the method provides a new idea for the synthesis of the intermediate A.
The invention provides a preparation method of a topramezone intermediate A shown as a formula A, wherein the intermediate A is obtained by reacting 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole in the presence of acid; the reaction formula is as follows:
further, in the above preparation method, the cyclic secondary amine is a cyclic secondary amine capable of reacting with 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol and paraformaldehyde to form a mannich base, which has a saturated or unsaturated five-membered ring or six-membered ring, a secondary amine group is located on the ring, the ring has a heteroatom except nitrogen or no heteroatom except nitrogen, and the ring has a substituent or no substituent. Preferably, the cyclic secondary amine is pyrrole, morpholine or piperidine.
Further, in the above production method, the reaction is carried out in the presence of an acid. The acid is an inorganic acid capable of forming a salt with the cyclic secondary amine, such as hydrochloric acid, sulfuric acid, or the like. The acid is added in an equimolar amount to the cyclic secondary amine, or the acid may be in slight excess.
Further, in the above production method, the reaction is carried out in the presence of a solvent. The reactants are reacted in the environment of water and organic solvent, the water is brought by acid, the organic solvent is selected from organic solvent which can keep the reaction homogeneous and miscible with water and does not react with each reactant and product, such as alcohol solvent, and the organic solvent is preferably ethanol in view of environmental protection and cost.
Furthermore, in the preparation method, each organic solvent has little influence on the reaction, the dosage of the organic solvent has no special requirement, and the homogeneous reaction of each reactant can be ensured, the reaction is easy to carry out, and the utilization rate of the reaction vessel is high.
Further, the 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol used in the present invention can be prepared according to the methods reported in the prior art, for example, according to the literature: prepared by the method disclosed in Journal of Agricultural and Food Chemistry (2008), 56 (22), 10805-10810. 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is commercially available.
Further, in the reaction, mannich reaction is carried out on 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-ol, paraformaldehyde and cyclic secondary amine in the presence of acid, and then 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is added for reaction to obtain an intermediate A. The adding sequence of the 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, the paraformaldehyde, the cyclic secondary amine, the acid and the solvent is not strict, and the materials can be mixed according to the random adding sequence, can be added at one time, can be added in batches, can be added continuously, can be added in a pure substance form, and can also be dissolved in the solvent in advance and added in a solution form. The 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole can be added in one portion, in portions, continuously, in a pure form, or dissolved in a solvent to form a solution.
Further, in the above-mentioned preparation method, 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole may be reacted in a theoretical molar ratio, preferably in the case where paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole are slightly excessive. In one embodiment of the invention, 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, cyclic secondary amine, and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole are present in a ratio of 1:1.0-1.5:1.0-1.5:1.0-1.3, and the molar weight of paraformaldehyde is calculated as formaldehyde.
Furthermore, in the preparation method, the temperature of the Mannich reaction is 60-80 ℃, the reaction can be rapidly carried out at the reaction temperature, the reaction time is slightly different due to different temperature ranges, and the reaction is judged to be finished when the content of the raw materials is extremely low. After adding 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole, the reaction is also carried out at 60 ℃ to 80 ℃.
Further, in the preparation method, 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, paraformaldehyde, cyclo-secondary amine, acid and a solvent are mixed and reacted at 60-80 ℃, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is added after the 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol is reacted completely, and the reaction is continued to be kept at the constant temperature until the 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is reacted completely. The progress of the reaction can be checked by HPLC methods.
Furthermore, in the preparation method, the post-treatment of the reaction liquid is simple and extensive, the organic solvent is removed from the reaction liquid after the reaction, then a proper amount of water is added, the mixture is stirred and crystallized, and the final product can be obtained by suction filtration. The organic solvent can be removed from the reaction solution by distillation, reduced pressure distillation, rotary evaporation, or the like.
The invention also provides a preparation method of the sulfuryl pyraflufen-ethyl, which comprises the step of synthesizing the intermediate A according to the method.
Further, the method for synthesizing the sulfuryl pyraflufen-ethyl comprises the steps of performing alkylation reaction on the intermediate A and difluorochloromethane to obtain an intermediate B and performing oxidation reaction on the intermediate B and hydrogen peroxide to obtain the sulfuryl pyraflufen-ethyl. The process route of the whole reaction process is as follows:
further, the specific processes for synthesizing the intermediate B and synthesizing the xaflufen from the intermediate B can be performed according to methods reported in the prior art, for example, according to the method described in patent CN102666502A, which belongs to the prior art and will not be described herein again.
In a specific embodiment of the present invention, the reaction between the intermediate a and difluoromethane chloride is performed in the presence of an organic solvent and an acid-binding agent, wherein the acid-binding agent is any substance reported in the prior art that can consume an acid formed by the reaction, and sodium carbonate, potassium carbonate, or triethylamine is commonly used. The organic solvent is a feasible organic solvent reported in the prior art, such as acetonitrile and the like.
In one embodiment of the invention, the molar ratio of intermediate a to difluoromethane chloride is 1:1.2-3, the reaction temperature is 10-30 ℃, the content of the intermediate A is detected by HPLC in the reaction process, and the reaction is finished when the intermediate A is completely reacted. After the reaction is finished, the by-product salt is removed by filtration, and the reaction solution can be directly used for the next reaction without extracting a product.
In a specific embodiment of the invention, the molar ratio of the intermediate B to hydrogen peroxide is 1 to 5 to 10, and the reaction temperature of the intermediate B and hydrogen peroxide is 60 to 80 ℃. The concentration of the hydrogen peroxide can be selected at will, and higher concentration is generally selected. The content of the intermediate B is detected by HPLC at all times during the reaction process, and the reaction is finished when the intermediate B is completely reacted. And after the reaction is finished, removing the organic solvent by reduced pressure distillation, and filtering the generated solid to obtain the sulfuryl pyraflufen-ethyl.
The invention has the advantages that:
(1) 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole are reacted to obtain an intermediate A, and a new idea is provided for the synthesis of the intermediate A.
(2) In the synthesis process of the intermediate A, paraformaldehyde is used for replacing an easily teratogenic formaldehyde hydrosolvent, so that the method is more environment-friendly.
(3) The reaction condition for synthesizing the intermediate A is mild, excessive temperature and high pressure are not needed, and the requirement on equipment is low.
(4) The post-treatment of the intermediate A is simple and extensive, the reaction product is easy to separate, the production process is simplified, and the method is more suitable for industrial mass production.
(5) The reaction of the intermediate A does not need a special catalyst, the reaction selectivity is high, the reaction yield is high, the product purity is high, and the total yield of the sulfonepyraflufen-ethyl is more than 81%.
Detailed description of the preferred embodiment
The present invention is further illustrated by the following specific examples. The following description is merely exemplary in nature and is in no way intended to limit the scope of protection. Other embodiments, which may be made by those skilled in the art without inventive faculty, are also within the scope of the invention.
In the following examples, unless otherwise specified, the concentrations are mass percent concentrations.
In the following examples, all the raw materials were commercially available products unless otherwise specified.
In the following examples, yield = actual mass of product x purity/theoretical mass of product.
Example 1
1. Synthesis of an intermediate A:
adding 16.6g of 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, 3g of paraformaldehyde, 8.5g of piperidine and 10g of 37% hydrochloric acid aqueous solution into 40mL of ethanol in sequence at room temperature, heating to 80 ℃, stirring for reaction for 4hr, detecting by HPLC that no 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol remains, adding 21.6g of 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole, continuing to react for 4hr, detecting by HPLC that 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is completely reacted, removing ethanol by reduced pressure evaporation after the reaction is finished, adding 20mL of water, pulping for 2hr, performing suction filtration to obtain a white solid precipitate, drying to obtain 28.8g of a solid, namely an intermediate A, the purity of which is 99.4% by HPLC, and the yield is 92.6% based on that of 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol.
2. And (3) synthesizing an intermediate B:
6.9g of potassium carbonate and 14.4g of the intermediate A are added into 40mL of acetonitrile, the mixture is stirred for 2 hours at the temperature of 20 ℃, difluorochloromethane gas is slowly introduced for 8.5g at normal pressure, HPLC detects that the intermediate A completely reacts after 8 hours, after the reaction is finished, the solid is removed by filtration, and the mother liquor is directly used for the next reaction.
3. Synthesis of the sulfone pyraflufen-ethyl:
adding 28.3g of 30wt% hydrogen peroxide into the reaction liquid in the step 2 at room temperature, stirring for 1hr, slowly heating to 60 ℃ for reaction, and after 4hr, detecting by HPLC to show that the reaction is finished. After removing acetonitrile by vacuum concentration, the reaction liquid is cooled to room temperature, and is filtered to obtain 16.8g of white solid, namely the sulfuryl pyraoxystrobin, the content of which is 98.4 percent by the intermediate A through HPLC detection, and the yield of the sulfuryl pyraoxystrobin is 84.5 percent.
Example 2
1. Synthesis of an intermediate A:
adding 33.2g of 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, 6g of paraformaldehyde, 14.2g of pyrrole and 20g of 37% hydrochloric acid aqueous solution into 80mL of ethanol in sequence at room temperature, heating to 75 ℃, stirring for reaction for 4hr, detecting by HPLC (high performance liquid chromatography), adding 43.2g of 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole after no 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol is left, continuing to react, detecting by HPLC after continuing to react for 4hr, removing the ethanol from the reaction liquid by reduced pressure distillation, adding 20mL of water, pulping for 2hr, performing suction filtration to obtain a white solid precipitate, drying to obtain 57.5g of solid, namely an intermediate A, wherein the purity is 99.2% by HPLC, and the yield is 92.3% based on 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol.
2. And (3) synthesizing an intermediate B:
10.6g of sodium carbonate and 30.9g of the intermediate A are added into 40mL of acetonitrile, the mixture is stirred for 2 hours at the temperature of 20 ℃, difluorochloromethane gas is slowly introduced at the temperature of 15g under normal pressure, HPLC detects the complete reaction of the intermediate A after 8hours, the solid is removed by filtration after the reaction is finished, and the mother liquor is directly used for the next reaction.
3. Synthesis of the sulfone pyraflufen-ethyl:
adding 113.3g of 30wt% hydrogen peroxide into the reaction solution in the step 2 at room temperature, stirring for 1hr, slowly heating to 60 ℃ for reaction, and after 4hr, detecting by HPLC to show that the reaction is finished. Concentrating under reduced pressure to remove acetonitrile, cooling to room temperature, and filtering to obtain 34.1g of white solid, namely the pyriflufen-ethyl, wherein the content of the pyriflufen-ethyl is 98.1% by HPLC detection, and the yield of the pyriflufen-ethyl is 87.5% based on the intermediate A.
Example 3
Synthesis of an intermediate A:
adding 33.2g of 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, 6g of paraformaldehyde, 17.4g of morpholine and 20g of 37% hydrochloric acid aqueous solution into 80mL of ethanol in sequence at room temperature, heating to 60 ℃, stirring and reacting for 4hr, detecting by HPLC that no 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol is left, adding 43.2g of 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole, continuing to react for 4hr, detecting by HPLC, ending the reaction, evaporating ethanol under reduced pressure after the reaction, adding 20mL of water, pulping for 2hr, filtering to obtain a white solid precipitate, drying to obtain 56.8g of solid, namely an intermediate A, wherein the purity is 99.3% by HPLC, and the yield is 91.3% by 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol.
2. And (3) synthesizing an intermediate B:
10.6g of sodium carbonate and 30.9g of intermediate A are added into 40mL of acetonitrile, the mixture is stirred for 2hr at 20 ℃, difluorochloromethane gas is slowly introduced into the mixture for 1lg at normal pressure, the reaction of the intermediate A is detected by HPLC after 8hr, the solid is removed by filtration after the reaction is finished, and the mother liquor is directly used for the next reaction.
3. Synthesis of the sulfone pyraflufen-ethyl:
adding 56.6g of 30wt% hydrogen peroxide into the reaction liquid in the step 2 at room temperature, stirring for 1hr, slowly heating to 80 ℃ for reaction, and after 4hr, detecting by HPLC to show that the reaction is finished. Concentrating under reduced pressure to remove acetonitrile, cooling to room temperature, and filtering to obtain 33.1g of white solid, namely the sulfuryl pyraflufen-ethyl, wherein the content of the sulfuryl pyraflufen-ethyl is 98.7% by HPLC detection, and the yield of the sulfuryl pyraflufen-ethyl is 83.5% by the intermediate A.
Claims (15)
1. A preparation method of a sulfonepyrazoxazole intermediate A shown as a formula A is characterized by comprising the following steps: obtained by reacting 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, cyclic secondary amine and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole in the presence of an acid; the reaction formula is as follows:
the cyclic secondary amine is pyrrole, morpholine or piperidine, and the acid is an inorganic acid capable of forming a salt with the cyclic secondary amine.
2. The method for preparing a polycarbonate resin composition according to claim 1, wherein: the acid is hydrochloric acid or sulfuric acid.
3. The method according to claim 1 or 2, characterized in that: firstly, 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol, paraformaldehyde and cyclic secondary amine react in the presence of acid, and then 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole is added for reaction.
4. The method according to claim 1 or 2, characterized in that: the temperature of the whole reaction is 60-80 ℃.
5. The method for preparing a polycarbonate according to claim 1 or 2, wherein: the solvent of the reaction is a mixture of water and an organic solvent, which is an organic solvent miscible with water.
6. The method according to claim 5, wherein: the organic solvent is an alcohol solvent.
7. The method of claim 6, wherein: the organic solvent is ethanol.
8. The method according to claim 1 or 2, characterized in that: 1-methyl-3- (trifluoromethyl) -1H-pyrazol-5-ol, paraformaldehyde, a cyclic secondary amine, and 5, 5-dimethyl-3-mercapto-4, 5-dihydroisoxazole as described in 1:1.0-1.5:1.0-1.5:1.0 to 1.3 in a molar ratio.
9. A preparation method of sulfuryl pyraflufen-ethyl is characterized by comprising the following steps: the method comprises the step of synthesizing an intermediate A according to the synthesis method of the intermediate A of the sulfone pyraflufen-ethyl shown as the formula A in any one of claims 1 to 8.
10. The method of claim 9, wherein: the method also comprises the steps of carrying out alkylation reaction on the intermediate A and difluorochloromethane to obtain an intermediate B, and carrying out oxidation reaction on the intermediate B and hydrogen peroxide to obtain the topramezone, wherein the reaction formula is as follows:
11. the method of claim 10, wherein: the reaction of the intermediate A and the chlorodifluoromethane is carried out in the presence of an acid-binding agent.
12. The method of claim 11, wherein: the acid-binding agent is sodium carbonate, potassium carbonate or triethylamine.
13. The method of claim 10, wherein: the molar ratio of the intermediate A to the difluoromethane chloride is 1:1.2-3.
14. The method of claim 10, wherein: the reaction solvent of the intermediate A and the chlorodifluoromethane is acetonitrile, and the reaction temperature is 10-30 ℃.
15. The method of claim 10, wherein: the reaction temperature of the intermediate B and hydrogen peroxide is 60-80 ℃, and the molar ratio of the intermediate B to hydrogen peroxide is 1 to 5-10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010489058.2A CN113754648B (en) | 2020-06-02 | 2020-06-02 | Preparation method of xaflufen and intermediate thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010489058.2A CN113754648B (en) | 2020-06-02 | 2020-06-02 | Preparation method of xaflufen and intermediate thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113754648A CN113754648A (en) | 2021-12-07 |
| CN113754648B true CN113754648B (en) | 2023-02-17 |
Family
ID=78782703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010489058.2A Active CN113754648B (en) | 2020-06-02 | 2020-06-02 | Preparation method of xaflufen and intermediate thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113754648B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230391762A1 (en) * | 2021-08-12 | 2023-12-07 | Upl Limited | A process for preparation of pyroxasulfone |
| CN114213402A (en) * | 2021-12-01 | 2022-03-22 | 芮城华农生物化学有限公司 | Metastable-state and stable-state crystal forms of xaflufen-ethyl, preparation method and application |
| CN114716428B (en) * | 2022-05-06 | 2024-02-06 | 山东潍坊润丰化工股份有限公司 | Method for preparing metazopyr intermediate |
| CN114989157A (en) * | 2022-06-28 | 2022-09-02 | 安徽久易农业股份有限公司 | Crystal form A of pyraflufen-ethyl and preparation method and application thereof |
| CN114957233A (en) * | 2022-07-05 | 2022-08-30 | 淄博新农基作物科学有限公司 | Sulfoxapyrazole and preparation method thereof |
| CN117229273B (en) * | 2023-11-13 | 2024-02-02 | 江苏七洲绿色化工股份有限公司 | Preparation method of metazachlor and intermediate thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006024820A1 (en) * | 2004-09-03 | 2006-03-09 | Syngenta Limited | Isoxazoline derivatives and their use as herbicides |
| DE102005031583A1 (en) * | 2005-07-06 | 2007-01-25 | Bayer Cropscience Gmbh | Process for the preparation of 3-arylmethylthio and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| WO2007071900A1 (en) * | 2005-12-21 | 2007-06-28 | Syngenta Limited | Novel herbicides |
| EP2065373A1 (en) * | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl) sulfinyl]-4,5-dihydroisoxazole derivatives, methods for their preparation and their use as herbicides and plant growth regulators |
| CN110511216A (en) * | 2018-05-22 | 2019-11-29 | 东莞市东阳光农药研发有限公司 | Isoxazoline derivative and its application in agricultural |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4317445B2 (en) * | 2001-06-21 | 2009-08-19 | クミアイ化学工業株式会社 | Isoxazoline derivatives and herbicides |
-
2020
- 2020-06-02 CN CN202010489058.2A patent/CN113754648B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006024820A1 (en) * | 2004-09-03 | 2006-03-09 | Syngenta Limited | Isoxazoline derivatives and their use as herbicides |
| DE102005031583A1 (en) * | 2005-07-06 | 2007-01-25 | Bayer Cropscience Gmbh | Process for the preparation of 3-arylmethylthio and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| CN101213181A (en) * | 2005-07-06 | 2008-07-02 | 拜尔作物科学股份公司 | Method for producing 3-arylmethylthio--4,5-dihydro-isoxazoline derivative and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivative |
| WO2007071900A1 (en) * | 2005-12-21 | 2007-06-28 | Syngenta Limited | Novel herbicides |
| EP2065373A1 (en) * | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl) sulfinyl]-4,5-dihydroisoxazole derivatives, methods for their preparation and their use as herbicides and plant growth regulators |
| CN110511216A (en) * | 2018-05-22 | 2019-11-29 | 东莞市东阳光农药研发有限公司 | Isoxazoline derivative and its application in agricultural |
Non-Patent Citations (2)
| Title |
|---|
| Spin Crossoverin Dinuclear N4S2 Iron(II) Thioether-Triazole Complexes:Access to [HS-HS],[HS-LS],and [LS-LS] States;R.W. Hogue等;《Inorg.Chem.》;20160415;第55卷;4152-4165 * |
| Virtual Screening of Acyclovir Derivatives as Protential Antiviral Agents：Design，Synthesis,and Biological Evaluation of New Acyclic Nucleoside;Marco Derudas等;《J. Med. Chem.》;20170822;第60卷;7876-7896 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113754648A (en) | 2021-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113754648B (en) | Preparation method of xaflufen and intermediate thereof | |
| CN113135867B (en) | S- (5, 5-dimethyl-4, 5-dihydroisoxazol-3-yl) ethyl acetate and synthetic method and application thereof | |
| CN111574511A (en) | Synthesis method and application of sulfuryl pyraflufen | |
| CN113754647B (en) | Synthesis method of sulfuryl pyraflufen-ethyl and intermediate thereof | |
| RU2074854C1 (en) | Method of synthesis of derivatives of o-(2-hydroxy-3-piperidino-1-propyl)-nicotinic acid amideoxime and their salts (variants), o-(2-hydroxy-3-piperidino-1-propyl)-nicotinic acid amideoxime pure crystalline base | |
| CN115073441B (en) | Synthesis method of topiramate intermediate | |
| RU2344124C1 (en) | Method of 2-n-phenylamino-2-cyanoadamantane or its derivatives production | |
| CN117327016A (en) | Preparation method of fenpyrad intermediate | |
| AU2021366441A1 (en) | A process for the preparation of chlorantraniliprole | |
| CN110818686B (en) | Synthetic method of imidacloprid | |
| CN114292228A (en) | Synthetic method of clodinafop-propargyl | |
| KR100881890B1 (en) | Process for preparation of Sarpogrelate HCl salt | |
| CN111100071A (en) | Method for synthesizing 2-cyano-5-aryl-1H-imidazole compound | |
| CN116120190B (en) | Method for preparing o-nitroaniline compound and application of o-nitroaniline compound | |
| SU1616904A1 (en) | Method of producing n-nitrophenylhydrazine | |
| CN117924265B (en) | Synthesis method of pyrifos | |
| CN115557914B (en) | Green synthesis method of furazan compound | |
| CN103333101B (en) | Pyridyl sulfoximine compound and preparation method thereof | |
| CN116410151A (en) | 3- (5, 5-dimethyl-4, 5-dihydroxyisoxazol-3-yl) propionate and synthetic method and application thereof | |
| WO2017037296A1 (en) | Stable adducts of 2-iodoxybenzoic acid | |
| SU292965A1 (en) | Method of producing N-carbamoyl-o-phenylenediamine derivatives | |
| CN118026937A (en) | Synthesis method of intermediate of haloxyfop-methyl for pesticides | |
| JPS6256149B2 (en) | ||
| CN117945991A (en) | Novel synthetic method of 3-chloro-2-hydrazinopyridine | |
| RU2235096C1 (en) | 2-ethylamino-4-piperidyl-6-[4'-methylcarbonyl-5'-methyl-1',2',3'- triazol)- 1-yl]-1,3,5-triazine as antidote |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |